A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Clinical trial NCT07549412 · RECRUITING
Trial details
- NCT number
- NCT07549412
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-06
- Primary completion
- 2029-10-16
- Enrollment
- 1020
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.